A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes?
Open Access
- 25 March 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6213
Abstract
A recent evaluation of the published data regarding the PCOS topic has highlighted a paradox in the definition of this condition. Even though the name of the syndrome refers to ovarian dysfunction, it seems that patients diagnosed with PCOS are more likely affected by an endocrine and metabolic issue. The term PCOS might not be appropriate to indicate the phenotypes described by the Rotterdam criteria, since the only phenotype with a gynecological issue alone is PCOS phenotype D. This novel perspective regarding how PCOS is currently defined leads the way to a reinterpretation of the entire pathological context and the treatment prescribed, such as inositols. A new point of view on the etiopathogenesis of the disease completely changes the current meaning of PCOS and consequently the therapeutic rationale evaluated to date.Keywords
This publication has 54 references indexed in Scilit:
- Criteria, prevalence, and phenotypes of polycystic ovary syndromeFertility and Sterility, 2016
- Pregnancy complications in women with polycystic ovary syndromeHuman Reproduction Update, 2015
- The polycystic ovary syndrome: a position statement from the European Society of EndocrinologyEuropean Journal of Endocrinology, 2014
- Divergences in Insulin Resistance Between the Different Phenotypes of the Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2013
- Insulin-stimulated release of d-chiro-inositol–containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndromeMetabolism, 2008
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2006
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Diagnoses, syndromes, and diseases: a knowledge representation problem.2003
- Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary SyndromeNew England Journal of Medicine, 1999
- Amenorrhea associated with bilateral polycystic ovariesAmerican Journal of Obstetrics and Gynecology, 1935